Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative Intent Treatment
Emory University
Emory University
Vanderbilt University Medical Center
OHSU Knight Cancer Institute
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
City of Hope Medical Center
Sir Run Run Shaw Hospital
Duke University
Fudan University
IHU Strasbourg
University of Oxford
University of Southern California
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Case Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Vanderbilt-Ingram Cancer Center